Home > Healthcare > Medical Devices > Diagnostic Devices > ECG Stress Test Market
ECG Stress Test Market size was valued at around USD 2.3 billion in 2022 and is expected to grow at 8.1% CAGR from 2023 to 2032.The market revenue is estimated to reach over USD 5.2 billion in 2032 driven by Increasing awareness levels related to need of maintaining a healthy lifestyle and getting early diagnosis of different heart related diseases.
Additionally, the surge in digitization and automation of healthcare facilities along with integration of next-generation technologies to offer advanced and improved care to patients will complement the market expansion. Rise in healthcare expenditure, considerable growth in number of people suffering from various respiratory disorders, and increased instances of pulmonary illnesses such arrhythmia, among other factors are projected to contribute to market progress.
A stress test, also known as treadmill test or exercise test, is used to measure the health of the heart during physical activity. The test involves walking on a treadmill or a stationary bike that allows the healthcare professional to monitor patient's heart rhythm, breathing rate and blood pressure during the test through an ECG system. An ECG stress test can estimate if the person has any risk of having heart disease.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
ECG Stress Test Market Size in 2022: | USD 2.3 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8.1% |
2032 Value Projection: | USD 5.2 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 150 |
Tables, Charts & Figures: | 194 |
Segments covered: | Product Type, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
High cost of instruments used in ECG stress test and lack of experienced staff performing the test especially in underdeveloped countries is anticipated to impede the market share. For instance, the stress test machines can cost in the range of USD 4,000 to USD 9,000. Healthcare facilities with limited capital budgets find it difficult to deploy such systems. Moreover, the cost of stress tests for uninsured patients can go up to around USD 5,000.